PHARMAC documents that matched your search:
25 June 2012 Media release Steffan Crausaz appointed PHARMAC Chief Executive PHARMAC Board chairman Stuart McLauchlan has today announced the appointment of Steffan Crausaz as PHARMAC’s Chief Executive. Steffan Crausaz has been the Government pharmaceutical-funding agency’s acting Chief Executive since…
Final version 2 of the Prescription for Pharmacoeconomic Analysis – known by many as “the PFPA”. The PFPA has high importance to PHARMAC as it describe the approach we take when doing cost-utility analysis – the form of analysis that provides information on the relative cost-effectiveness of a pharmaceutical compared to other funding options.